HEPARIN SODIUM INJECTION for intravenous or subcutaneous use
HEPARIN SODIUM INJECTION is an anticoagulant indicated for. (1). •. Prophylaxis and treatment of venous thrombosis and pulmonary embolism.
Orig s lbl
DOSAGE FORMS AND STRENGTHS---
HEPARIN SODIUM INJECTION for intravenous or subcutaneous use HEPARIN SODIUM INJECTION is an anticoagulant indicated for (1):.
s s lbl
NDA 17-037/S-158 Page 3 - Heparin Sodium Injection USP
It is to be administered by intravenous or deep subcutaneous routes. The potency is determined by a biological assay using a USP reference standard based on
s lbl
Heparin Sodium Injection USP
It is to be administered by intravenous or deep subcutaneous routes. The potency is determined by a biological assay using a USP reference standard based on
s
Reference ID: 4350531
See full prescribing information for HEPARIN SODIUM INJECTION. HEPARIN SODIUM INJECTION for intravenous or subcutaneous use. Initial U.S. Approval: 1939.
s lbl
Reference ID: 2974610
HEPARIN SODIUM INJECTION for intravenous or subcutaneous use HEPARIN SODIUM INJECTION is an anticoagulant indicated for (1):.
s lbl
Heparin Sodium Injection USP
Peak plasma levels of heparin are achieved 2 to 4 hours following subcutaneous administration although there are considerable individual variations.
Orig s lbl
4 HEPARIN SODIUM 5 INJECTION USP
Heparin Sodium Injection USP is a sterile solution of heparin sodium derived from 22 to be administered by intravenous or deep subcutaneous routes.
s s lbl
HEPARIN SODIUM INJECTION USP
After deep subcutaneous (intrafat) injections tests for adequacy of dosage are best performed on samples drawn four to six hours after the injections. Periodic
s lbl
Heparin Sodium Injection USP
It is to be administered by intravenous or deep subcutaneous routes. The potency is determined by a biological assay using a USP reference standard based on
s lbl